No Data
No Data
Savara Announces New Employment Inducement Grant
Savara Shares Are Trading Higher After the Company Announced Encore Presentations for Its Phase 3 IMPALA-2 Trial.
CORRECTION: Savara Ticker Is "SVRA"
Savara Announces Encore Presentations From Phase 3 IMPALA-2 Trial Of Molgramostim Inhalation Solution In Patients With Autoimmune Pulmonary Alveolar Proteinosis At Two Upcoming Scientific Conferences
Savara Announces Encore Presentations From the Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (APAP) at Two Upcoming Scientific Conferences
Express News | Savara Announces Encore Presentations From the Phase 3 Impala-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (Apap) at Two Upcoming Scientific Conferences